News Roundup: August 21 to August 25


Your weekly roundup of the latest news from Drug Topics®.

FDA Delays Drug Supply Chain Security Act Deadline Until November 2024

The FDA has issued a 1-year delay on the final enhanced drug distribution security requirements under the Drug Supply Chain Security Act (DSCSA) that were set to take effect in November.

Read More

How AI Can Improve Controlled Substance Security

Each year, drug diversion is estimated to cost the US health care system an estimated $70 billion. Outside of these costs, drug diversion poses a significant risk to patient safety and patient’s communities.

Read More

In A Post-Dobbs World, Pharmacists Still Face Uncertainty

Legal challenges have made dispensing abortion medications more difficult than ever.

Read More

Study Highlights Importance of Preventive Cancer Screenings on Health, Economy

Preventative cancer screenings have added millions of years to the lives of Americans and have saved the United States economy trillions of dollars, according to recent research published in the journal BMC Health Services Research.

Read More

FDA Approves Pfizer RSV Vaccine for Use During Pregnancy to Protect Infants

The FDA has approved Pfizer’s bivalent respiratory syncytial virus (RSV) vaccine (Abrysvo) for use during pregnancy to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by RSV in infants from birth through 6 months.

Read More

Related Videos
© 2024 MJH Life Sciences

All rights reserved.